Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or

Alessio Bruni1, Vieri Scotti2, Paolo Borghetti3

  • 1Radiotherapy Unit, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Frontiers in Oncology
|December 6, 2021
PubMed